Detalhe da pesquisa
1.
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.
Lancet Oncol
; 24(2): 175-186, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681089
2.
A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma.
Invest New Drugs
; 37(4): 755-762, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172443
3.
Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series.
Ann Surg Oncol
; 24(6): 1546-1550, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28058556
4.
OPTIMIZING LENVATINIB THERAPY IN PATIENTS WITH METASTATIC RADIOACTIVE IODINE-RESISTANT DIFFERENTIATED THYROID CANCERS.
Endocr Pract
; 23(10): 1254-1261, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28816536
5.
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
PLoS Genet
; 10(2): e1004135, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24550739
6.
Surgical resection of synchronously metastatic adrenocortical cancer.
Ann Surg Oncol
; 22(1): 146-51, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25092161
7.
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.
Invest New Drugs
; 31(5): 1201-6, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23887852
8.
A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261.
Gynecol Oncol
; 127(1): 55-62, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22664059
9.
Mutated BRAF and personalised medicine in differentiated thyroid cancer.
Lancet Oncol
; 17(9): 1181-3, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27460441
10.
Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas.
J Endocr Soc
; 6(5): bvac044, 2022 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35402763
11.
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive Chemoradiotherapy.
Pract Radiat Oncol
; 12(2): 113-119, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34715395
12.
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
Head Neck
; 44(6): 1277-1300, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274388
13.
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.
Lancet Oncol
; 11(10): 962-72, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20851682
14.
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer.
J Clin Oncol
; 39(21): 2359-2366, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961488
15.
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
Thyroid
; 31(3): 337-386, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33728999
16.
Bone metastases in thyroid cancer.
J Bone Oncol
; 21: 100282, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154098
17.
Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy.
J Clin Endocrinol Metab
; 105(7)2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32421817
18.
Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma.
J Endocr Soc
; 4(7): bvaa069, 2020 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666013
19.
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.
J Immunother Cancer
; 8(2)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737143
20.
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.
Thyroid
; 30(9): 1254-1262, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32538690